LHCAX Mutual Fund

LHCAX Mutual Fund

NAV$24.86
See how much of LHCAX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Apr 30, 2026

Net Assets
-
Expense Ratio
1.03%
Dividend Yield (Current)
0.14%
Holdings
64
Inception Date
Jul 31, 2019
Fund Family
Lord Abbett Family of Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+3.29%
1 Year+28.62%
3 Year+9.01%
5 Year+3.55%

Asset Allocation

Stocks: 96.38%
Cash: 1.69%
Other: 1.93%
See how much of LHCAX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report is $25, once. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co.8.89%
AZN:LNAstraZeneca PLC4.73%
GILDGilead Sciences4.25%
JNJJohnson & Johnson - Common3.19%
NKTRNektar Therapeutics3.17%
Top 10 Concentration: 37.55%Report Date: Apr 30, 2026
Download all 64 holdings for LHCAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.14%
Frequency
Annually
Latest Distribution
$1.47
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

LHCAX Mutual Fund Overview

LHCAX Mutual Fund (Lord Abbett Health Care Fund) is managed by Lord Abbett Family of Funds. LHCAX expense ratio is 1.03%, holding 64 positions across sectors including Health Care, Financials, Industrials. Inception date: 2019-07-31.

LHCAX performance shows a YTD return of 3.29%. The 1-year return is 28.62% and the 5-year return is 3.55%. LHCAX dividend yield stands at 0.14%, paid annually.

LHCAX top holdings include Eli Lilly & Co. (8.9%), AstraZeneca PLC (4.7%), Gilead Sciences (4.3%), Johnson & Johnson - Common (3.2%), Nektar Therapeutics (3.2%). Go to all LHCAX holdings, LHCAX sectors, or LHCAX dividends.

LHCAX can be compared against other funds. Use LHCAX overlap to find shared positions, or LHCAX vs another fund for a side-by-side view. LHCAX alternatives are available via the screener, along with tax-loss harvesting opportunities.